Image-guided biopsy can help patients avoid unnecessary kidney removalMay 01, 2006Percutaneous image-guided biopsy of renal masses is safe and accurate, and it frequently alters clinical decision making, says a new study from the University of Michigan. For the study, the researchers reviewed 153 kidney biopsies in 126 patients. The researchers found that more than 60% of patients had a change in their treatment-whether surgery, tumor ablation, chemotherapy or radiation-due to biopsy results, and that as many as 75 unnecessary kidney removals were potentially avoided. "When a patient has a kidney mass, options include an open surgical procedure or an image-guided percutaneous biopsy. Percutaneous means that the procedure is performed through the skin, through a tiny incision (only 3-4 mm). Imaging guidance (either ultrasound or CT) allows us to watch our needle as it enters the mass, decreasing the risk of damage to adjacent structures and ensuring that we are sampling the correct tissue," said Katherine Maturen, MD, lead author of the study. According to the researchers, these procedures are performed under conscious sedation with local anesthesia to numb the skin where the needle will enter. The procedure takes about half an hour in most cases, and after a four-hour observation period, patients are free to go home. According to the researchers, although the acceptance of percutaneous image-guided biopsy has increased among physicians in recent years, many continue to avoid the biopsies because of concerns about poor sensitivity and a high rate of non-diagnostic biopsy, all based on data from old techniques including fine needle aspiration. "We felt it was important to demonstrate that newer core biopsy techniques have a much greater success rate, and to quantify the extent to which these biopsies altered patient management," said Dr. Maturen. "When a patient has a kidney mass, it isn't always clear what the treatment should be until we know the tissue type. Sometimes getting a small sample of tissue can make the difference between major surgery (partial or complete removal of the kidney) or a simple follow-up CT scan. If a mass is benign, a patient has been spared the loss of a kidney and may actually need no treatment at all. If a mass is malignant but something other than a cancer of kidney origin, the treatment may involve chemotherapy, radiation or another type of surgery entirely," said Dr. Maturen. The full results of the study will be presented on Monday, May 1, 2006 during the American Roentgen Ray Society Annual Meeting in Vancouver, BC. American Roentgen Ray Society |
|||||||||||||||||||||
| Related Biopsy Current Events and Biopsy News Articles Engineer designs micro-endoscope to seek out early signs of cancer Traditional endoscopes provide a peek inside patients' bodies. Now, a University of Florida engineering researcher is designing ones capable of a full inspection. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Barrow study identifies new way to biopsy brain tumors in real time A new miniature, hand-held microscope may allow more precise removal of brain tumors and an easier recognition of tumor locations during surgery. Routine evaluation of prostate size not as effective in cancer screening, Mayo study finds New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. For young boys with cancer, testicular tissue banking may be option to preserve fertility For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility. Mount Sinai finds those with more difficult to treat forms of HCV are half as likely to get treated A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. Hundreds of genes distinguish patients likely to survive advanced melanoma Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. New finding suggests prostate biopsy is not always necessary Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy. Does prostate-specific antigen velocity help in early detection prostate cancer? The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer detection. Researcher: 'Optical biopsy' for breast cancer increasingly accurate But women may not have to endure the medical costs, stress and potential complications that accompany such invasive biopsies forever. A University of Florida biomedical engineering researcher is making progress on an "optical biopsy" that has the potential to determine whether growths are cancerous without ever puncturing the skin. More Biopsy Current Events and Biopsy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||